How to read this list: every vendor below is drawn from CVC's own vendor dataset (the same records used across the site's directory and profile pages). No stats, review counts, or "independently verified" claims are shown for any vendor - CVC's records mark review scores for these vendors as unpublished, and capability descriptions are vendor-reported or CVC-compiled from public sources, not audited by CVC. Full inclusion criteria are in the "How we selected these 10" section below.
Article last reviewed: 18 August 2026 (against vendor records last reviewed 28 March 2026).
What "digital clinical trial capability" means here
Decentralized clinical trials (DCT) move parts of a study away from a fixed investigator site - home nursing visits, remote/wearable monitoring, virtual consultations, direct-to-patient drug and sample logistics, and eConsent. Sponsors researching this space are usually trying to answer one question: which vendors actually run this kind of trial, as opposed to vendors that merely mention "digital" in their marketing. This article answers that question using only what is already recorded in CVC's vendor dataset.
How we selected these 10
We started from every vendor in CVC's dataset carrying the Home Health / DCT (decentralized trials) category flag - 52 vendors as of this review - and separately checked the AI / Machine Learning and eCOA / ePRO categories, plus every vendor's summary, positioning, and strengths text sitewide, for explicit decentralized/virtual/remote-monitoring/wearable/eConsent capability language. That produced a pool of 54 candidate records.
From that pool we selected the 10 whose CVC record positions virtual or decentralized trial delivery as the vendor's own stated specialty - not an incidental flag, a partner's technology, or a single logistics function. We excluded:
- Courier and specimen-logistics providers (e.g. direct-to-patient shipping arms) - essential to DCT execution, but not trial-delivery organisations themselves.
- Patient concierge/logistics agencies whose record describes coordination services rather than running trial activity.
- Single-purpose digital-measures or device vendors (wearables, microsampling, autoinjectors, at-home diagnostics, adherence apps) - real DCT-enabling technology, but not CROs.
- Home-nursing / home-visit execution providers whose record describes mobile nursing or in-home visits without a broader virtual-trial or decentralized-platform specialty of their own - eleven such vendors were identified and are legitimate DCT execution partners, just not "top 10 CRO" candidates for this specific list.
- A retail pharmacy trial-access channel and a digital-trial consulting firm - real DCT-adjacent capability, but neither is a trial-running CRO.
Ranking is disclosed, not a hidden score. Vendors whose CVC record names "virtual trial platform" or "decentralized/hybrid trial services" as their defining specialty are ranked above vendors whose primary described capability is home-visit or community-site execution support. Within each group, vendors with global, multi-phase (Phase I-IV) coverage per their CVC record are ranked above those with narrower geographic or phase coverage, which is noted individually below. This ordering reflects what each vendor's own record emphasises - it is not a claim that the #1 vendor outperforms #10 on every dimension, and sponsors should evaluate any shortlist against their specific protocol needs.
Paid/featured (sponsored) status exists as a flag in CVC's dataset but was not used as a ranking input - none of the 10 vendors below carry that flag.
The 10 CROs
1. Science 37
CVC's record lists Science 37's specialty focus as a "virtual trial platform" - one of the earliest and most cited fully virtual, decentralized trial operators, running trial delivery as a platform rather than as an add-on to a site network.
2. Lightship
CVC's record describes Lightship's focus as "decentralized and hybrid trial services; virtual sites" - a purpose-built decentralized/hybrid trial operator that runs virtual sites directly rather than subcontracting the decentralized layer.
3. Curavit Clinical Research
CVC's record describes Curavit's focus as "virtual clinical site; decentralized and FSP-style support" - combining a virtual-site delivery model with functional-service-style support for sponsors.
4. ObvioHealth
CVC's record lists ObvioHealth's focus as a "virtual trial platform." Note: CVC's record currently shows Phase I-II coverage only, narrower than the Phase I-IV coverage shown for the other entries on this list - worth confirming directly with the vendor for later-phase programmes.
5. THREAD DCT
CVC's record describes THREAD's focus as "remote, hybrid and decentralized trial workflows" - a workflow-level specialist spanning fully remote through hybrid trial designs.
6. Huma Clinical Trials
CVC's record describes Huma's focus as "AI-first clinical research and remote evidence generation" - a digital health company running remote evidence-generation studies with an AI-first product approach.
7. Care Access Research Direct
CVC's record flags Care Access Research Direct's strengths as "patient convenience, decentralized execution, visit flexibility." Its CVC summary is a general sponsor-facing capability statement rather than a named specialty phrase, which is why it is ranked below entries with more specific record text.
8. EmVenio Research
CVC's record describes EmVenio's focus as "community-based and in-home research access" - extending trial reach into community and home settings beyond a fixed site.
9. Hawthorne Health
CVC's record describes Hawthorne Health's focus as "home visits; community site network; hybrid trial operations." Note: CVC's record shows a USA-only footprint, narrower than the global coverage shown for most other entries on this list.
10. Illingworth Research Group
CVC's record describes Illingworth's focus as "mobile research nursing and patient concierge" - a global mobile-nursing and patient-concierge model supporting decentralized visit delivery.
Vendors we considered but didn't include
Forty-four of the 54 candidate records were not selected. That is not a quality judgement on all of them - several, particularly the eleven home-nursing/home-visit execution providers in CVC's directory (mobile phlebotomy and in-home visit specialists), are genuine DCT execution partners worth shortlisting alongside the 10 above depending on your protocol's needs. They were excluded from this specific "top 10 CRO" cut because their CVC record describes a single execution function rather than a broader virtual-trial or decentralized-platform specialty. Courier/logistics providers, patient-concierge agencies, single-purpose device or digital-measures vendors, a retail pharmacy channel, and a consulting firm were excluded because they are not themselves trial-running CROs. The full directory, including all 52 Home Health/DCT-flagged vendors, is browsable on CVC.
Browse the full vendor directory, including every Home Health / DCT-flagged vendor referenced in this article's methodology.
Browse Vendors More Insights